Avanos Medical (AVNS) Price to FCF (2014 - 2026)

Avanos Medical has disclosed Price to FCF across 13 years of filings, most recently posting 39.39 for Q1 2026.

• In Q1 2026, Price to FCF fell 212.96% year-over-year to 39.39; the TTM figure through Mar 2026 stood at 87.19 (up 1400.09% YoY), while the FY2025 annual figure was 12.1, up 37.14% from the prior year.
• Price to FCF came in at 39.39 for Q1 2026 at Avanos Medical, down from 24.49 in the prior quarter.
• In the past five years, Price to FCF ranged from a high of 152.31 in Q4 2023 to a low of 495.42 in Q1 2022.
• Average Price to FCF over 5 years is 27.98, with a median of 34.87 recorded in 2025.
• The largest YoY upside for Price to FCF was 248.39% in 2023 against a maximum downside of 424.26% in 2023.
• Over 5 years, Price to FCF stood at 43.72 in 2022, then soared by 248.39% to 152.31 in 2023, then sank by 90.95% to 13.78 in 2024, then soared by 77.74% to 24.49 in 2025, then slumped by 260.82% to 39.39 in 2026.
• Per Business Quant data, the three most recent Price to FCF figures were 39.39 in Q1 2026, 24.49 in Q4 2025, and 76.65 in Q3 2025.